Remove Cannabis Remove History Remove Seminar Remove Treatment
article thumbnail

MAPS Is Pushing For FDA Approval Of MDMA-Assisted Therapy

Veriheal

How MAPS Plans To Help MAPS has been at the forefront of psychedelic research for decades, funding studies, seminars, and conferences to promote proper education and harm reduction about a myriad of substances. If the measure passes, MDMA will make history as the first psychedelic approved for pharmaceutical use.

Therapy 89
article thumbnail

The John Hopkins Center for Psychedelic and Consciousness Research Publishes Inaugural Edition Of Newsletter

Cannabis Law Report

The growth and management of psychedelics regulation will be equally chaotic, but we think just as fast as the cannabis sector. The interview features a patient’s testimony after receiving treatment at the Center. Medium recently featured a piece on the treatment of Anorexia at the center. December 3, 2019. December 4, 2019.

Therapy 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Medical publications, are, in the main fairly positive toward cannabis. Published by The Journal of Cannabis Research. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. At the same time, the outlook on cannabis research data is largely positive. Background.

article thumbnail

Behind the Scenes on Cannabis Normalization With JM Pedini

The Cannigma

The same can be said for changing public attitudes towards cannabis. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. That’s the one that surely getting traction right now, and very likely may be the first bill that legitimizes the cannabis industry that succeeds at the federal level.

Access 81